AU528067B2 - Process for preparing 8-(4(4-(2-pyrimidinyl)-1-piperazinyl) butyl)-8-azaspiro(4,5)decane-7,9-dione - Google Patents

Process for preparing 8-(4(4-(2-pyrimidinyl)-1-piperazinyl) butyl)-8-azaspiro(4,5)decane-7,9-dione

Info

Publication number
AU528067B2
AU528067B2 AU76041/81A AU7604181A AU528067B2 AU 528067 B2 AU528067 B2 AU 528067B2 AU 76041/81 A AU76041/81 A AU 76041/81A AU 7604181 A AU7604181 A AU 7604181A AU 528067 B2 AU528067 B2 AU 528067B2
Authority
AU
Australia
Prior art keywords
azaspiro
decane
dione
piperazinyl
pyrimidinyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU76041/81A
Other languages
English (en)
Other versions
AU7604181A (en
Inventor
Robert R. Covington
David L. Temple
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Co
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of AU7604181A publication Critical patent/AU7604181A/en
Application granted granted Critical
Publication of AU528067B2 publication Critical patent/AU528067B2/en
Anticipated expiration legal-status Critical
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/20—Spiro-condensed ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/30—Halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/34—One oxygen atom
    • C07D239/36—One oxygen atom as doubly bound oxygen atom or as unsubstituted hydroxy radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AU76041/81A 1980-12-11 1981-10-05 Process for preparing 8-(4(4-(2-pyrimidinyl)-1-piperazinyl) butyl)-8-azaspiro(4,5)decane-7,9-dione Expired AU528067B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US21521480A 1980-12-11 1980-12-11
US215214 1980-12-11

Publications (2)

Publication Number Publication Date
AU7604181A AU7604181A (en) 1982-07-15
AU528067B2 true AU528067B2 (en) 1983-04-14

Family

ID=22802113

Family Applications (1)

Application Number Title Priority Date Filing Date
AU76041/81A Expired AU528067B2 (en) 1980-12-11 1981-10-05 Process for preparing 8-(4(4-(2-pyrimidinyl)-1-piperazinyl) butyl)-8-azaspiro(4,5)decane-7,9-dione

Country Status (18)

Country Link
JP (1) JPS57122082A (de)
AT (1) AT380686B (de)
AU (1) AU528067B2 (de)
BE (1) BE891446A (de)
CA (1) CA1172255A (de)
CH (1) CH647518A5 (de)
DE (1) DE3149011A1 (de)
DK (1) DK154560C (de)
FI (1) FI73993C (de)
FR (1) FR2496105B1 (de)
GB (1) GB2089341B (de)
GR (1) GR76331B (de)
IE (1) IE51948B1 (de)
IT (1) IT1172073B (de)
LU (1) LU83833A1 (de)
NL (1) NL8105529A (de)
SE (1) SE444438B (de)
YU (1) YU42432B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU212301B (en) * 1989-04-28 1996-05-28 Alkaloida Vegyeszeti Gyar Process for producing buspirone
US5484788A (en) * 1993-03-26 1996-01-16 Beth Israel Hospital Association Buspirone as a systemic immunosuppressant
US5631017A (en) * 1993-03-26 1997-05-20 Beth Israel Deaconess Medical Center, Inc. Topical application of buspirone for treatment of pathological conditions associated with immune responses
KR950014099A (ko) * 1993-11-10 1995-06-15 장기하 N-(2-피리미딜)피페라지닐 부틸아미드의 제조방법
US5637314A (en) * 1995-06-07 1997-06-10 Beth Israel Deaconess Medical Center, Inc. Topical and systemic application of buspirone or derivatives thereof for treating atopic dermatitis

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE759371A (fr) * 1969-11-24 1971-05-24 Bristol Myers Co Azaspirodecanediones heterocycliques et procedes pour leur preparation
DE2341925A1 (de) * 1973-08-20 1975-03-06 Thomae Gmbh Dr K Neue pyrimidinderivate und verfahren zu ihrer herstellung

Also Published As

Publication number Publication date
JPH0113476B2 (de) 1989-03-06
IE51948B1 (en) 1987-04-29
FI813937L (fi) 1982-06-12
DE3149011C2 (de) 1988-08-25
SE444438B (sv) 1986-04-14
IE812897L (en) 1982-06-11
SE8107446L (sv) 1982-06-12
FR2496105A1 (fr) 1982-06-18
DK154560B (da) 1988-11-28
FI73993B (fi) 1987-08-31
YU42432B (en) 1988-08-31
GR76331B (de) 1984-08-04
ATA529581A (de) 1985-11-15
FR2496105B1 (fr) 1985-12-13
DE3149011A1 (de) 1982-07-15
CH647518A5 (de) 1985-01-31
DK154560C (da) 1989-04-17
CA1172255A (en) 1984-08-07
JPS57122082A (en) 1982-07-29
AT380686B (de) 1986-06-25
DK548081A (da) 1982-06-12
GB2089341A (en) 1982-06-23
AU7604181A (en) 1982-07-15
IT1172073B (it) 1987-06-18
BE891446A (fr) 1982-06-11
GB2089341B (en) 1984-09-19
NL8105529A (nl) 1982-07-01
IT8149718A0 (it) 1981-11-16
FI73993C (fi) 1987-12-10
YU243681A (en) 1984-02-29
LU83833A1 (fr) 1982-07-07

Similar Documents

Publication Publication Date Title
AU555797B2 (en) 2(4-((4-dialkyl-2,6-piperidinedion-1-yl)butyl)-1- piperazinyl)pyrimidines
DK307590D0 (da) Analogifremgangsmaade til fremstilling af 8-(4-(4-(2,1-benzisothiazol-3-yl)-1-piperazinyl)butyl)-8-azaspiro(4.5)decan-7,9-dion
YU43256B (en) Process for producing subst.2-or 4-(phenoxyalkyl-4)-or 2-piperazinylalkyl-1,2,4-triazole-3-one
AU560667B2 (en) 2(4-((4,4-dialkyl-2,6-piperidinedion-1-yl) butyl)-1-piperazinyl)pyrimidines
IE812420L (en) Spiro compounds
AU528325B2 (en) 3,4-dichlorophenyl-2-imidazoline (or pyrmidine)- methanol derivatives
AU528067B2 (en) Process for preparing 8-(4(4-(2-pyrimidinyl)-1-piperazinyl) butyl)-8-azaspiro(4,5)decane-7,9-dione
PT73270B (en) Process for preparing novel pyrimidine derivatives
AU534542B2 (en) 4-(substituted)thio-1-b-d-ribofuranosyl pyrazolo- (3,4-d) pyrimidine derivatives
HUT40088A (en) Process for preparing 8-halogen-5,6-dialkoxy-quinazolin-2,4-dione derivatives
AU588671B2 (en) 4-(2-pyrimidinyl)-1-piperazinyl heterocyclic carbonyl derivatives
CS122288A2 (en) Method of 8-(4-(4-(2-pyrimidinyl)-1-piperazinyl) butyl)-8-aza-spiro (4,5)-decane-7,9-dione preparation
DE3267778D1 (en) Process for producing 2,4-diamino-(3,5-dimethoxy-4-methoxy-ethoxy-benzyl)-pyrimidine
EP0101517A4 (de) NEUE s-TRIAZOL(1,5-a)PYRIMIDINABKÖMMLINGE.
YU42774B (en) Process for obtaining 2,4-diamino-5-(3',4',5'-trimethoxybenzyl)-pyrimidine
YU240282A (en) Process for preparing 4-(3-methly-2-butenyl)1,2-diphenyl-3,5-dioxopyrazolidine
FI821234A0 (fi) Foerfarande foer framstaellning av 8-(4-(4-(2-pyrimidinyl)-1-piperazinyl)-butyl)-8-azaspiro(4,5)dekan-7,9-dion
YU64686A (en) Process for preparing 2,4,6-trisubstituted derivatives 5-(3,4,5-trimetoxibenzyl)-pyrimidine
YU138482A (en) Process for obtaining 2,4-diamino-5-(3',4',5'-trimethoxybenzy)pyrimidine

Legal Events

Date Code Title Description
MK14 Patent ceased section 143(a) (annual fees not paid) or expired